Search

everythinglearnresearchcommunity

for

Search:↓

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

Menopause causes skin and hair to become drier and thinner, but hormone therapy can improve these conditions.

Finasteride was more effective than hydroxychloroquine in treating frontal fibrosing alopecia.

Imiquimod can cause rare skin side effects, some irreversible, and long-term follow-up is important for users.

Early treatment is key for permanent hair loss disorders, with options ranging from medications and phototherapy to immunomodulators and antibiotics, depending on severity and type.

New understanding and treatments for hair loss are improving, but more research is needed.

The conclusion is that dermatologists need to improve prescription practices to reduce errors and drug interaction risks.

Ixekizumab successfully treated a rare hair loss condition, leading to complete hair regrowth.

The combination treatment showed some improvement but wasn't significantly better than using betamethasone valerate alone.

Some treatments for hair loss, like finasteride, biotin, and minoxidil, can be effective, but their success varies by individual case.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

PRP treatments and hair transplantation may be linked to the progression of pseudolymphoma to lymphoma.

The article concludes that understanding Frontal Fibrosing Alopecia (FFA) is crucial for effective treatment, which includes medication like 5α-reductase inhibitors and hydroxychloroquine.

The review suggests more research is needed to understand Frontal fibrosing alopecia, a condition causing hairline recession in postmenopausal women.

Two unusual cases showed that Lichen Planopilaris can look like other skin conditions and need early treatment to protect hair.

The document's conclusion cannot be provided because the document is not readable or understandable.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Oral and topical finasteride are effective and safe for treating female hair loss.

Intralesional corticosteroids and 5-alpha-reductase inhibitors are the best treatments for frontal fibrosing alopecia.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

Stopping sunscreen use on the forehead led to hair regrowth in a woman with frontal fibrosing alopecia.

Methotrexate effectively treated a 2-year-old's generalized pustular psoriasis without side effects.

An 8-year-old girl with vitiligo developed extra hair growth on her knee after using tacrolimus ointment.

A 10-year-old girl with Fox Fordyce disease improved with treatment, suggesting the disease can occur before puberty and might be underdiagnosed in young girls.

UVA1-light therapy successfully treated a child's skin condition, mycosis fungoides.

Fox Fordyce disease might be more common in prepubertal girls than thought and can be managed with treatment.

Fox Fordyce disease can occur in prepubertal girls and may be underdiagnosed.

Alopecia areata in infants may be more common than previously thought.

Accidentally eating a topical steroid may rarely cause acute generalized pustular psoriasis.

The new wound dressing with minoxidil and dexamethasone could speed up healing and reduce scarring in rats.